How Clinicians Interpret Genomics With Standard Labs
Why genomic findings, symptoms, medication history, and conventional laboratory results belong in one review.
By Kure Health Clinical Education Team · Reviewed September 22, 2026
Short answer
Genomics adds context; standard labs assess current clinical markers. A clinician compares both with symptoms, history, medications, and risk before deciding whether any action or confirmation is appropriate.
Three layers of information
Inherited architecture describes predisposition. Methylation describes a changing regulatory pattern. Current clinical signals show what may require attention now. None is the whole patient.
From report to prioritised questions
The goal is not to generate the longest supplement list. It is to identify which findings are relevant, which need confirmation, and which may not change care.
What this means at Kure
AgeCode is one layer of Signal-Based Medicine. We review inherited architecture and methylation patterns alongside current symptoms, history, medications, standard laboratory findings, and other diagnostics. A report supports a clinical conversation; it does not make the decision alone.
Educational information only. Genomic and epigenetic associations do not diagnose disease or guarantee an outcome. Do not change medication or treatment without a qualified clinician.